Catalyst
Slingshot members are tracking this event:
Takeda Provides Update on EU Marketing Authorization Application for NINLARO (ixazomib) in Relapsed/Refractory Multiple Myeloma
- Source Link:
- http://www.takeda.com/news/2016/20160527_7418.html
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TKPYY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 27, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Relapsed/refractory Multiple Myeloma, Ninlaro, Ixazomib, Eu Marketing Authorization
